Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioVaxys Technology Corp. BVAXF


Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.


CSE:BIOV - Post by User

Comment by javaman12on Oct 27, 2024 2:15pm
41 Views
Post# 36284085

RE:BioVaxys (BIOV) Biotech is an Alternative Investment To Gold

RE:BioVaxys (BIOV) Biotech is an Alternative Investment To GoldHopefully for those now fully invested, we blow throught the remaining few 7.5 cent asks, fairly quickly! Some person or group, quietly accumulating, at these lower price levels is trying to keep the price down, as long as possible. 

No potential seller would want to keep a lower price in place. And a 1000 share sell order at the end of the trading day has no other purpose. 

The real volume of trades is being made at 7.5 cents. On Monday do we get some much better value for our shares?

                                            It takes as long as it takes!

                     No worries, that's how this fickle market, always seems to work!

                               There is a lot of new buying interest in these shares!

                                                   That's why I am here!

                                                      All the best! Java
<< Previous
Bullboard Posts
Next >>